switch from semaglutide to retatrutide Switching Tirzepatide Switching from tirzepatide to retatrutide:

34 In the double-blind study, seven patients received subcutaneous exenatide twice daily and eight patients received placebo

Lisdexamfetamine (Vyvanse) remains the only FDA-approved medication for binge eating disorder

66 However, for most individuals on GLP-1s aiming for healthy weight loss and muscle preservation, the 1.2-1.6 g/kg range is a solid target

NauckMANiedereichholzUEttlerRHolstJJOrskovCRitzelRet al

Document the medical necessity for combining GLP-1 medications with other compounds for specific medical conditions

Emerging research suggests that genetics may influence aspects of GLP-1 signalling and incretin response, which may partly explain why individuals differ in satiety, insulin response, or weight-loss outcomes